# contextual query Exc L6 IT

Query: The following is a list of genes enriched in tumour microenvironment cells from a (human) patient with glioblastoma  annotated as Neurons (Exc).  What might this list say about the state, properties and interactions of this cell type?  Do not limit your answers to the cancer literature,  include normal cell-cell interactions, development and cross-cutting metabolic states.  Gene list: ['MEG3', 'DPP10', 'RALYL', 'CTNNA2', 'KCNIP4', 'SYT1', 'RYR2', 'CSMD1', 'RBFOX1', 'STXBP5L']

The gene list you provided—**MEG3, DPP10, RALYL, CTNNA2, KCNIP4, SYT1, RYR2, CSMD1, RBFOX1, STXBP5L**—represents a cohort of genes highly enriched in cells annotated as **excitatory neurons** within the glioblastoma (GBM) tumor microenvironment. Analysis of their known functions and expression profiles offers insights into the **state, properties, and potential interactions** of these neuronal populations both in normal and diseased contexts.

### Functional Overview and Implications

#### 1. **Neuronal Identity and Maturation**
Several genes on your list are well-established markers of **mature excitatory neurons**:
- **SYT1 (Synaptotagmin 1)**: Key for synaptic vesicle exocytosis and neurotransmitter release, reflecting functional synaptic machinery.
- **RBFOX1, RALYL**: RNA-binding proteins involved in alternative splicing in neurons, supporting neuronal differentiation and synaptic identity.
- **KCNIP4, RYR2**: Regulate neuronal excitability and calcium signaling, crucial for action potential firing and synaptic transmission.

The **enrichment** of these genes suggests the neuronal cells identified are not undifferentiated or glial-like but retain a mature, excitatory phenotype.

#### 2. **Synaptic Organization and Connectivity**
- **CTNNA2 (Catenin alpha 2)**: Involved in dendritic spine and synapse structure, contributing to synaptic connectivity and plasticity.
- **STXBP5L**: Participates in vesicle docking and release at synapses.

Such genes imply these cells potentially maintain **functional synapses** and may interact both with other neurons and, relevantly, with tumor cells through synaptic or paracrine mechanisms.

#### 3. **Cell–Cell Interactions in the Tumor Microenvironment**
- **CSMD1**: Known for roles in synaptic pruning and modulating complement activity at synapses, possibly influencing immune/neuron cross-talk.
- **MEG3**: A long non-coding RNA with tumor suppressive properties, involved in neuronal differentiation and response to cellular stress.

Given recent findings, there is growing evidence that **glioblastoma cells exploit neuronal activity and synaptic factors** for their own growth and invasion. Neuronal genes regulating glutamate signaling, calcium flux, and synaptic formation may directly support or get co-opted into tumor-promoting pathways[1][2].

#### 4. **Activity-Dependent and Developmental States**
Some genes (e.g., **RYR2, CTNNA2**) are expressed during neuronal development but persist in mature neurons to support activity-dependent responses. Their maintained expression could reflect:
- Ongoing **activity-dependent signaling** (supporting synaptic plasticity or adaptation).
- Potential response to tumor-induced changes in the microenvironment, possibly driven by local glutamate or calcium dynamics[1][2].

#### 5. **Normal and Pathological Interactions**
In normal contexts, these genes support:
- **Neuronal communication** (e.g., synaptic transmission, plasticity).
- **Structural maintenance** of circuits.
- **Metabolic homeostasis** needed for high activity.

In glioblastoma, these properties could be subverted:
- **Functional neuronal–tumor synapses** have been identified, where neuronal activity drives tumor proliferation[1][2].
- Tumor cells may respond to neurotransmitters (notably glutamate), and vice versa, neurons may alter their state or fate in response to tumor-derived factors.

### Summary Table: Gene Functions and Inferences

| Gene      | Key Neuronal Role                | Relevance to State/Interactions        |
|-----------|----------------------------------|---------------------------------------|
| MEG3      | lncRNA, differentiation, tumor suppression | Stress response, tumor interaction   |
| DPP10     | Modulates potassium (Kv4) channels | Excitability, synaptic integration   |
| RALYL     | RNA-binding, modulates neuron-specific transcripts | Maturation, plasticity            |
| CTNNA2    | Synaptic/dendritic architecture   | Connectivity, plasticity               |
| KCNIP4    | Potassium channel regulation      | Firing properties, excitability        |
| SYT1      | Calcium sensor, vesicle exocytosis | Neurotransmission, synaptic function  |
| RYR2      | Intracellular Ca2+ release        | Activity-dependence, plasticity        |
| CSMD1     | Synaptic pruning, complement regulation | Immune–neuron interactions          |
| RBFOX1    | RNA splicing in neurons           | Splicing, activity adaptation          |
| STXBP5L   | Vesicle docking/release           | Synaptic transmission                  |

### Cross-Cutting Metabolic and Developmental States

The **combined expression** of these genes suggests these neuronal cells are:
- **Mature, functionally active** excitatory neurons,
- Capable of **dynamic responses** to input (including from tumor cells),
- Potential contributors to, and affected by, **tumor–neuron signaling loops**,
- Possibly exhibiting changes in **calcium signaling** and **synaptic structure** in response to the tumor microenvironment[1][2].

In sum, this gene profile characterizes a population of neurons maintaining excitatory identity and robust synaptic features, with the capacity for dynamic interaction with glioblastoma cells and the wider tumor microenvironment, influencing both normal brain function and tumor progression.



## References

- [1] CNSC-14. T-TYPE CALCIUM CHANNELS REGULATE NEURON-GLIOBLASTOMA INTERACTIONS AND PROMOTE TUMOR GROWTH https://academic.oup.com/neuro-oncology/article/25/Supplement_5/v25/7406334 2023-11-01 None
- [2] Microenvironment T-Type calcium channels regulate neuronal and glial processes to promote glioblastoma growth http://biorxiv.org/lookup/doi/10.1101/2024.08.22.609229 2024-08-23 None
- [3] Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model https://linkinghub.elsevier.com/retrieve/pii/S2372770517300104 2016-06-22 None
- [4] Abstract 2534: Neural control of glioma infiltration https://aacrjournals.org/cancerres/article/82/12_Supplement/2534/702133/Abstract-2534-Neural-control-of-glioma 2022-06-15 None
- [5] CNSC-11. INVESTIGATION OF GLIOBLASTOMA NEURON-TUMOR NETWORKS WITH RABIES-BASED RETROGRADE TRACING https://academic.oup.com/neuro-oncology/article/26/Supplement_8/viii42/7890075 2024-11-01 None